Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours

Anticancer Research

Volumn 28, Issue 6 B, 2008, Pages 3897-3907

  Chen, ZhiHeng ^a   Zhou, Hui ^a   Li, Henglan ^a   He, Ellen ^b,c   Hu, Jiyong ^d   Zhou, Ji ^d   Skog, Sven ^b,c,e  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Sino Swed Molecular Bio Medicine Research Institute   (China)

^d Sino Swed Tongkang Bio Tech Inc   (China)

^e NONE   (Sweden)

Author keywords

Benign; Cancer; Fatty liver; Health screening; Infection; Inflammation; Malignancy; Thymidine kinase 1; TK1; Tumour; Virus

Indexed keywords

THYMIDINE KINASE 1;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CHEMOLUMINESCENCE; CONTROLLED STUDY; FATTY LIVER; FEMALE; HELICOBACTER INFECTION; HEPATITIS B; HUMAN; KIDNEY TUMOR; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE TUMOR; SEROLOGY;

ADULT; AGED; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASMS; THYMIDINE KINASE; TUMOR MARKERS, BIOLOGICAL;

EID: 58149156699     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ulmert D, Cronin AM, Bjork Th, O'brien MF, Scardino PT, Eastam JA, Becker Ch, Berglund G, Vickers AJ and Lija H: Prostatic-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study. BMC Medicine 6: 6, 1-22, 2008.
2. He Q, Zou L, Zhang PA, Lui JX, Skog S and Fornander T: The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody. Int J Biol Markers 15: 139-146, 2000.
3. Zou L, Zhang PG, Zou S, Li Y and He Q: The half-life of thymidine kinase 1 in serum measured by ECL dot blot: a potential marker for monitoring the response to surgery of patients with gastric cancer. Int J Biol Markers 17: 135-140, 2002.
4. Li HX, Zhang S, Lei DS, Wang XQ, Skog S and He Q: Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer. Oncol Rep 13: 145-149, 2005.
5. He Q, Zou L, Zhang PA, Li HX, Wang XQ, Zou S and Skog S: Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity. Oncol Rep 14: 1013-1019, 2005.
6. Zhang J, Jia Q, Zou S, Zhang P, Zhang X, Skog S, Luo P, Zhang W and He Q: Thymidine kinase 1: a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients. Oncol Rep 15: 455-461, 2006.
7. He Q, Fornander T, Johansson H, Johansson H, Hu GZ and Lars-Erik Rutqvist and Skog S: Thymidine kinase 1 in serum predicts increased risk of distant or locoregional recurrence following surgery in patients with early breast cancer. Anticancer Res 26: 4753-4759, 2006.
8. Wu CJ, Yang RJ, Zhou J, Bao S, Zou L, Mao YR and He Q: Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1. J Immunol Methods 277: 157-169, 2003.
9. Xu XH, Zhang YM, Shu XH, Shan LH, Wang ZW, Zhou YL, Wen HK, He F, He E and Skog S: Serum thymidine kinase 1 reflects the progression of premalignant and malignant tumors during therapy. Molecular Medicine Reports, in press.
10. Topolcan O and Holubec L Jr: The role of thymidine kinase in cancer diseases. Expert Opin Med Diagn 2: 129-141, 2008.
11. Kuebbing D and Werner R: A model for compartmentation of de novo and salvage thymidine nucleotide pools in mammalian cells. Proc Natl Acad Sci USA 72: 3333-3336, 1975.
12. Sauer H and Wilmanns W: Thymidine kinase. In: Methods of Enzymatic Analysis. Vol. 3. Bergmeyer, HU, Bergmeyer J, Grassl M (eds.). Florida, Verlag Chemie, pp. 468, 1983.
13. Elsevier SM, Kucherlapati RS, Nichols EA, Creagan RP, Giles RE, Ruddle FH, Willecke K and McDougall JK: Assignment of the gene for galactokinase to human chromosome 17 and its regional localisation to band q21-22. Nature 255: 633-636, 1974.
14. Lee LS and Cheng YC: Human deoxythymidine kinase. I. Purification and general properties of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia. J Biol Chem 251: 2600-2604, 1976.
15. Coppock DL and Pardee AB: Regulation of thymidine kinase activity in the cell cycle by a labile protein. J Cell Physiol 124: 269-274, 1985.
16. Sherley JL and Kelly TJ: Regulation of human thymidine kinase during the cell cycle. J Biol Chem 263: 8350-8358, 1988.
17. He Q, Skog S and Tribukait B: Cell cycle-related studies on thymidine kinase and its isoenzymes in Ehrlich ascites tumours. Cell Prolif 24: 3-14, 1991.
18. Kauffman MG and Kelly TJ: Cell cycle regulation of thymidine kinase: Residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis. Mol Cell Biol 11: 2538-2546, 1991.
19. Chang ZF and Cheng SM: Methylation-sensitive protein-DNA interaction at the cell cycle regulatory domain of human thymidine kinase promoter. Biochem Biophys Res Commun 189: 480-487, 1992.
20. Hengstschlager M, Knofler M, Mullner EW, Ogris E, Wintersberger E and Wawra E: Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells. J Biol Chem 269: 13836-13842, 1994.
21. He Q, Wang N, Skog S, Ericsson S and Tribukait B: Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Europ J Cell Biol 70: 117-124, 1996.
22. Birringer MS, Perozzo R, Kut E, Stillhart C, Surber W, Scapozza L and Folkers G: High-level expression and purification of human thymidine kinase 1: quaternary structure, stability, and kinetics. Protein Expr Purif 47: 506-515, 2006.
23. Gronowitz JS, Hagberg H, Kallander CF and Simonsson B: The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma. Br J Cancer 47: 487-495, 1983.
24. Gronowitz JS, Steinholtz L, Kallander CF, Hagberg H and Bergh J: Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers. Cancer 58: 111-118, 1986.
25. Munch-Petersen B, Cloos L, Jensen HK and Tyrsted G: Human thymidine kinase 1. Regulation in normal and malignant cells. Adv Enzyme Regul 35: 69-89, 1995.
26. Hengstschlager M, Pfeilstocker M and Wawra E: Thymidine kinase expression. A marker for malignant cells. Adv Exp Med Biol 431: 455-460, 1998.
27. Tanaka K, Sishido T, Morimoto M, Inoue S, Takamura Y and Masumura M: Elevated serum thymidine kinase activity in pateints with acute viral hepatitis. Gastroenterol Jpn 28: 51-55, 1993.
28. Turriziani O, Butera O, Gianotti N, Parisi SG, Mazzi R, Girardi E, Iaiani G, Antonelli L, Lazzarin A and Antonelli G: Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients. AIDS 19: 473-479, 2005.
29. Ellims PH, Hayman RJ and van der Weyden MB: Plasma thymidine kinase in megaloblastic anaemia. Br J Haematol 44: 167-168, 1980.
30. Gronowitz JS, Larsson A, Kallander CF, Claesson K, Sjöberg O, Lernestedt JO, Frödin L and Tufveson G: Serum thymidine kinase in transplant patients: its relation to cytomegalovirus activity, renal transplant rejection and its use for monitoring of antiviral therapy. Ann Clin Res 18: 71-75, 1986.
31. Tavassoli FA and Devilee P: World Health Organization: Tumours of the Breast and Female Genital Organs. IARC Press Lyon, p. 16, pp. 63-73, 2003.
32. Underwood JCE: General and systematic pathology. London, Churchill Livingstone, p. 46, pp. 201-222, pp. 223-262, pp. 370-375, pp. 410-432, 2004.
33. Yang L, Parkin DM, Ferlay J, Li L and Chen Y: Estimates of Cancer Incidence in China for 2000 and Projections for 2005. Cancer Epidemiol Biomark Prev 14: 243-250, 2005.
34. Forbes GM, Warren JR, Glaser ME, Cullen DJ, Marshall BJ and Collins BJ: Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol 11: 670-673, 1996.
35. Zhao D, Sun T, Zhang X, Guo Y, Yu D, Yang M, Tan W, Wang G and Lin D: Role of CD14 promoter polymorphisms in Helicobacter pylori infection - related gastric carcinoma. Clin Cancer Res 13: 2362-2368, 2007.